With 1.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.84 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $390.03 whereas the lowest price it dropped to was $380.45. The 52-week range on ELV shows that it touched its highest point at $567.26 and its lowest point at $357.45 during that stretch. It currently has a 1-year price target of $491.39. With its current market cap of 86.74 billion, ELV has annualized dividend of $6.68 while the current yield stands at 1.74%. ELV paid its most recent dividend on 1749513600, while the ex-dividend date for that was 1749513600. Beta for the stock currently stands at 0.62.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ELV was up-trending over the past week, with a rise of 1.31%, but this was down by -5.11% over a month. Three-month performance dropped to -9.03% while six-month performance fell -2.31%. The stock lost -29.04% in the past year, while it has gained 4.07% so far this year. A look at the trailing 12-month EPS for ELV yields 25.63 with Next year EPS estimates of 39.18. For the next quarter, that number is 9.20. This implies an EPS growth rate of 4.36% for this year and 13.62% for next year. EPS is expected to grow by 10.60% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 6.81%.
Float and Shares Shorts:
At present, 225.64 million ELV shares are outstanding with a float of 225.55 million shares on hand for trading. On 2025-05-15, short shares totaled 2.61 million, which was 114.99999999999999 higher than short shares on 1744675200. In addition to Ms. Gail Koziara Boudreaux as the firm’s President, CEO & Director, Mr. Mark Bradley Kaye serves as its Executive VP & CFO.
Institutional Ownership:
Through their ownership of 0.93031996 of ELV’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ELV since 12 analysts follow the stock currently. There are 11 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ELV analysts setting a high price target of 585.0 and a low target of 428.0, the average target price over the next 12 months is 500.7542. Based on these targets, ELV could surge 52.38% to reach the target high and rise by 11.48% to reach the target low. Reaching the average price target will result in a growth of 30.43% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $33.39177 being high and $32.43427 being low. For ELV, this leads to a yearly average estimate of $33.21035. Based on analyst estimates, the high estimate for the next quarter is $10.14 and the low estimate is $7.74. The average estimate for the next quarter is thus $8.68.
